Beximco Pharmaceuticals Ltd.
30th May, 2006
Beximco Pharma introduces 3 new Drugs First Time in Bangladesh
Leading drug manufacturer Beximco Pharmaceuticals Ltd (BPL) has introduced 3 new products for Insomnia, Respiratory & Urinary Tract Infections and for the prevention of Bronchospasm
The three new drugs namely S-Clon®, Evo® Solution and Respira® are first time launches from Beximco Pharma in Bangladesh, an official statement of the company said.
S-Clon® is a preparation of Eszopiclone. S-Clon® is available in two strengths- 1 mg & 2 mg tablets. S-Clon® (Eszopiclone) is used for the treatment of insomnia without tolerance and dependence, as approved by the US FDA. S-Clon® 1 tablet is available in 6 x 10’s pack and S-Clon® 2 tablet is available in 3 x 10’s pack. The price of each tablet of S-Clon® 1 mg and S-Clon® 2 mg are Tk. 2 and Tk. 3 respectively.
Evo® Solution is the preparation of Levofloxacin, a broad-spectrum antibacterial agent. Evo® Solution, a US FDA approved antibiotic solution for oral administration, is indicated to fight infections like Respiratory & Urinary Tract Infections, Skin and Soft Tissue Infections and Enteric fever. Evo® Solution is available as 25 mg/ 1 ml oral solution in 100 ml bottle. The price of each bottle of Evo® Solution is Tk. 75 only.
Another new drug, Respira® is indicated for the treatment or prevention of bronchospasm in adults, adolescents and children of or above 6 years of age with reversible obstructive airway disease. It contains Levosalbutamol and is available in two dosage forms, Respira® tablet and syrup. Respira® 1 mg tablet is available in 10 x10’s pack and Respira® 1mg/5ml syrup is available 100 ml bottle. The price of each tablet of Respira® 1 mg is 90 paisa only and each bottle of Respira® 100 ml syrup is Tk. 35.00 only.
Moreover, Respira® inhaler and Cesonide® (Ciclesonide, a new generation corticosteroid for asthma) inhaler are in the pipeline and will be introduced in the market very soon.
Note to the Editor
Beximco Pharmaceuticals Ltd is a leading edge pharmaceutical company based in Dhaka, Bangladesh and is a member of the BEXIMCO Group, the largest private sector industrial conglomerate in Bangladesh. Beximco Pharmaceuticals started its operation in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc of USA and now has grown to become nation’s one of the leading pharmaceutical companies, supplying approximately 10% of country’s total medicine need. Today Beximco Pharmaceuticals manufactures and markets its own ‘branded generics’ for almost all diseases from AIDS to cancer, from infection to asthma, from hypertension to diabetes, for both national and international markets. It also contract manufactures for major international brands of leading multinational companies.